• Regenerex Pharma terminated Chief Financial Officer Kenneth Perry for cause, with notice delivered May 2, 2026.
• Perry had been placed on paid administrative suspension effective March 31, 2026.
• Don E. Ray was appointed interim CFO on April 1, 2026 for an initial 90-day term.
• Independent directors concluded April 27, 2026 that Perry’s conduct represented a material, ongoing breach of his employment agreement; CEO recused from deliberations.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Regenerex Pharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001472375-26-000133), on May 06, 2026, and is solely responsible for the information contained therein.